US Stock MarketDetailed Quotes
REPL Replimune
- 12.490
- +0.480+4.00%
Close Dec 20 16:00 ET
- 12.490
- 0.0000.00%
Post 20:01 ET
941.00MMarket Cap-4.11P/E (TTM)
13.040High11.430Low2.35MVolume11.780Open12.010Pre Close29.54MTurnover4.65%Turnover RatioLossP/E (Static)75.34MShares17.00052wk High2.52P/B630.96MFloat Cap4.92052wk Low--Dividend TTM50.52MShs Float54.850Historical High--Div YieldTTM13.41%Amplitude4.920Historical Low12.567Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Replimune Stock Forum
The market overall advanced Friday. Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded +0.35%, the $Dow Jones Industrial Average (.DJI.US)$ climbed 0.97%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.16%.
MACRO
In macroeconomics, S&P Global released its composite and service PMI. Composite came in at a two-year high, 55.3...
$Super Micro Computer (SMCI.US)$ climbed 15%, after earlier this week, the firm said it submitted a plan to release its six-month delayed 10k with a new auditor, BDO USA, and filed for a time extension to file it...
Replimune Receives Breakthrough Therapy Designation for Rp1 and Submits Rp1 Biologics License Application to the FDA Under the Accelerated Approval Pathway
No comment yet